Ciramadol

This classification denotes an opioid receptor agonist with the molecular formula C15H23NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9NQ109OW0G, chemically known as phenol, 3-((r)-(dimethylamino)((1r,2r)-2-hydroxycyclohexyl)methyl)- but generally known as ciramadol, which bears US NIH Compound Identifier 44463. European Medicines Agency schedules Ciramadol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07477MIG. The term CIRAMADOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). CIRAMADOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ciramadol under HS 29225000 and SITC 51467. As of Q4 2014, CIRAMADOL remains the US FDA Preferred Term for this commodity. Ciramadol bears US NLM identifiers UMLS ID C0055779 and NCI Concept Code C77282. SMILES: OC1C(CCCC1)C(N(C)C)C1CC(O)CCC1.